Which risk factors predict the levodopa response in fluctuating Parkinson's disease?
β Scribed by M. W. I. M. Horstink; J. C. M. Zijlmans; J. W. Pasman; H. J. C. Berger; J. J. Korten; M. A. Van 't Hof
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 583 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The extent to which concomitant Alzheimer's disease (AD) is etiologically related to the development of dementia in Parkinson's disease (PD) remains controversial. We explored the association of four risk factors associated with AD, including head injury, smoking, hypertension, and diab
## Abstract Levodopa ethylester (LDEE), a highly soluble prodrug of levodopa, may overcome the impaired absorption of regular levodopa, due mainly to a combination of levodopa's poor solubility and delayed gastric emptying. We conducted a doubleβblind, levodopaβcontrolled, multicenter study of oral
## Abstract In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined __off__ states at 3 yearly intervals over a mean period of 11.4 years from the point of commencement of levodopa treatment. Twenty